Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief - Wikidata - wikimedia - TriplyDB

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

http://www.wikidata.org/entity/Q35092191

about

Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients.

P2860

Q40444488-B811F23F-8C24-4502-825F-22FC3633A4C9 Q50010598-E02C70B5-2181-41EB-8716-3FD2AE113CA7

P2860

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

http://www.wikidata.org/entity/Q35092191

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

@ast

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

@en

type

label

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

@ast

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

@en

prefLabel

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

@ast

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

@en

P1433

Q35092191-D87BD3CC-3E4A-4B8E-91BB-FEE2A8D380EC

P1476

Q35092191-4231C46D-718C-4037-A4CD-7A51487F253B

P2860

Q35092191-90C0A30A-79AF-4E84-8C41-D6A730E08874

Q35092191-9BF66E34-9F5A-4FC9-A938-1F425479A61C

Q35092191-B38FEAE9-21AD-43A9-94E6-F9D5FEC99B36

Q35092191-DE86E127-5B56-42F6-8FD3-C196E43E1D20

Q35092191-EA7AA8AD-EE73-4B9D-8A86-4242E3789D3A

P2888

Q35092191-C6F2338E-FB47-4E76-ABC9-B38EE1DB3B3F

P304

Q35092191-7A40D5C4-2B2B-4CAD-90F9-572620B010DC

P31

Q35092191-55010BFB-119A-4647-B10A-73EAB4ECF60C

P356

Q35092191-18FC760F-F232-4756-BB6C-75DD8F046A9A

P433

Q35092191-143E8551-112C-484F-BA6F-33716237F8FF

P478

Q35092191-24D2C9E7-8A6F-49F9-8892-1CFA05A78764

P50

Q35092191-ABF4B6A0-9CD2-4B99-A263-529FF0785F21

Q35092191-B82A8F49-2235-4D66-B152-88437D383752

P577

Q35092191-8031D5FC-2AB8-40AF-9353-E6713D0E4168

P5875

Q35092191-2A761F7A-D59C-49FA-A391-5BD8D9465358

P6179

Q35092191-BD1458ED-BBC6-4AC1-8418-5B888D7222AF

P698

Q35092191-7C5DD14D-D49F-4281-936F-64B22B0EB9C2

P932

Q35092191-2CB7C41C-B05A-4D60-9AA4-D7E893872062

P356

S13054-014-0510-4

P1433

P1476

Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief

@en

P2860

A word of caution regarding proposed benefits of albumin from ALBIOS: a dose of healthy skepticism.

Albumin: biochemical properties and therapeutic potential.

The clinical use of albumin: the point of view of a specialist in intensive care.

Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.

Albumin replacement in patients with severe sepsis or septic shock

P2888

s13054-014-0510-4

P304

510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13054-014-0510-4

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Luciano Gattinoni

P577

2014-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273953744

http://www.w3.org/2001/XMLSchema#string

P6179

1019062159

http://www.w3.org/2001/XMLSchema#string

P698

25672854

http://www.w3.org/2001/XMLSchema#string

P932

4331462

http://www.w3.org/2001/XMLSchema#string